Immune micro-environment analysis and drug screening for ovarian endometriosis
Genes & Genomics · 2024
DOI: 10.1007/s13258-024-01497-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Genomics, 2024. Verfasst von Qingli Quan und 3 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), …. Hauptthemen laut MEDLINE: Endometriosis, Killer Cells, Natural. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Medical Science and Technology Research Fund.
Abstract (Originalsprache)
BACKGROUND: Patients of ovary endometriosis have an abnormal immune micro-environment, leading to endometrial tissue that from retrograde menstruation evade immune surveillance and subsequently develop into ectopic lesions. OBJECTIVE: This study aims to elucidate the crucial immune cells and molecular pathways that are associated with an aberrant immune micro-environment of endometriosis. METHOD: In this study, we identified differentially expressed genes between ovarian ectopic endometrial tissue (OVE) and eutopic endometrial tissue from patients with endometriosis (PE) and non-endometriosis patients (CON) by analyzing the mRNA sequencing data. Additionally, we used WGCNA(Weighted Gene Co-expression Network Analysis) to screen for key genes related to immune cell infiltration and compared the sub-types of infiltrating immune cells using CIBERSORT(cell-type identification by estimating relative subsets of RNA transcript). Subsequently, we conducted a single-cell analysis on the identified key genes. Furthermore, we analyzed potential drugs suitable for ovarian endometriosis treatment using pRRophertic. RESULTS: Seven key genes associated with immune cell infiltration were screened out. The expression of these genes in OVE was significantly lower than that in PE and CON. These key genes were mainly enriched in the NK cell-mediated cytotoxicity pathway, especially for CD16 + CD56dim NK. Moreover, NK cells infiltration in ovarian endometriosis was significantly reduced compared with PE and CON, while M2 macrophage shown the opposite. Results of the single-cell analysis showed that the expression of the seven key genes in NK cells and monocyte-macrophages in OVE was significantly lower than that in PE or CON. Additionally, we identified potential drugs suitable for ovarian endometriosis treatment. CONCLUSION: The decreased infiltration of NK cells and increased infiltration of M2 macrophages contribute to the evasion of immune surveillance against endometrial tissue, promoting the progression of OVE. Therefore, potential strategies for the treatment of OVE include increasing NK cell activation and decreasing M2 macrophage polarization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), PO Box 510600, Guangzhou, China.
- NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), PO Box 510600, Guangzhou, China. 36052770@qq.com.
- Guangzhou Women and Children's Medical Center, Guangzhou Medical University, PO Box 510623, Guangzhou, China. yumeix509@163.com.
ORCID-Profile: Qingli Quan
Förderung
- National Natural Science Foundation of China
- Guangdong Medical Science and Technology Research Fund
Zitieren
APA
Quan, Q., Gu, H., Wang, Y., & Yu, M. (2024). Immune micro-environment analysis and drug screening for ovarian endometriosis. Genes & Genomics. https://doi.org/10.1007/s13258-024-01497-8
Vancouver
Quan Q, Gu H, Wang Y, Yu M. Immune micro-environment analysis and drug screening for ovarian endometriosis. Genes & Genomics. 2024. doi:10.1007/s13258-024-01497-8
BibTeX
@article{Quan2024,
author = {Quan, Qingli and Gu, Heng and Wang, Yongxia and Yu, Meixing},
title = {Immune micro-environment analysis and drug screening for ovarian endometriosis},
journal = {Genes & Genomics},
year = {2024},
doi = {10.1007/s13258-024-01497-8}
}
EUVIMED